Skip to main content
NAMS logo

NAMS · NewAmsterdam Pharma Co N.V.

Track NAMS — free
$25.33 -0.57 (-2.20%)
Market Cap
$3.10B
Shares
119.54M

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-08-11 52 $27.98 $1,455
2026-08-06 2,826 $27.42 $77,489
2026-08-05 8 $27.55 $220
2026-08-04 2,180 $27.49 $59,928
2026-08-03 2,038 $27.79 $56,636
2026-07-29 138 $27.98 $3,861
2026-07-24 500 $30.55 $15,275
2026-07-23 500 $31.70 $15,850
2026-07-22 500 $32.34 $16,170
2026-07-21 3,976 $29.67 $117,968
2026-07-17 2 $31.05 $62
2026-07-08 1,911 $36.99 $70,688
2026-06-30 6,500 $33.87 $220,155
2026-06-29 54,787 $33.24 $1,821,120
2026-06-26 95,964 $31.73 $3,044,938
2026-06-15 2,997 $30.40 $91,109
2026-06-10 35,709 $30.38 $1,084,839
2026-06-09 720 $30.95 $22,284
2026-06-02 8 $31.79 $254
Showing 1–19 of 19 settlements
Key facts CIK 1936258 CUSIP N62509109 13F (30d) 172 filings 170 filers Visit website Investor relations